- English
- 简体中文
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
Sinae APIs Categoria Factory
Active Pharmaceutical Ingredientia
| Progestogen et Estrogen | |||
| Product Name | Specification | Probatus | CAS Non. |
| Progesterone | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
| Pregnenolone | In domo |
Kosher | 145-13-1 |
| Medroxyprogesterone Acetate | CP/EP/USP | DMF/GMP | 71-58-9 |
| Megestrol acetate | CP/EP/USP | DMF in processusususus | 595-33-5 |
| Mifepristone | CP/IP | DMF/GMP | 84371-65-3 |
| Cyproterone Acetate | CP/EP | CEP/TGA/EU-GMP | 427-51-0 |
| Levonorgestrel | CP/EP/USP | CEP/GMP | 797-63-7 |
| Drospirenone | EP/USP | DMF | 67392-87-4 |
| Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
| Estradiol | CP/EP/USP | DMF/GMP | 35380-71-3 |
| Estriol | CP/EP/USP | Sub R&D | 50-27- 1 |
| Ethinyl Estradiol | CP/EP/USP | GMP | 57-63-6 |
| Estradiol Valerate | CP | DMF | 979-32-8 |
| Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
| Dienogest | EP | CEP | 65928-58-7 |
| Fulvestrant | In domo | Sub R&D | 129453-61-8 |
| Exemestane | EP/USP | Sub R&D | 107868-30-4 |
| Androgen | |||
| Product Name | Specification | Probatus | CAS Non. |
| Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
| Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
| Abiraterone Acetate | CP/USP | DMF/WC | 154229-18-2 |
| Testosterone | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
| Testosterone Undecanoate | CP | DMF/WC | 5949-44-0 |
| Testosterone Cypionate | USP | Sub R&D | 58-20-8 |
| DHEA(Prasterone) | FP/In domo | DMF/WC/Kosher | 53-43-0 |
| Clascoterone | In domo | DMF in processusususus | 19608-29-8 |
| Cortical Hormone | |||
| Product Name | Specification | Probatus | CAS Non. |
| Budesonide | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
| Desonide | USP | DMF/GMP | 638-94-8 |
| Eplerenone | EP | CEP in processu | 107724-20-9 |
| Methylprednisolone | CP/EP/USP | DMF/GMP | 83-43-2 |
| Methylprednisolone Hemisuccinate | CP/EP/USP | DMF/GMP | 2921-57-5 |
| Fluticasone Propionate | CP/EP/USP | DMF | 80474- 14-2 |
| Fluticasone Furoate | In domo | DMF in processusususus | 397864-44-7 |
| Mometasone Furoate |
EP/USP |
DMF in processusususus |
Anhydrous (83919-23-7) Monohydratorum (141646-00-6) |
| alii | |||
| Product Name | Specification | Probatus | CAS Non. |
| Oxcarbazepine | CP/EP/USP | CEP/FDA | 28721-07-5 |
| Eslicarbazepine Acetate | In domo | DMF | 236395- 14-5 |
| Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
| Valganciclovir Hydrochloride | USP | DMF | 175865-59-5 |
| Oseltamivir Phosphate | CP/EP/USP | DMF | 204255- 11-8 |
| Baloxavir Marboxil | In domo | Sub R&D | 1985606-14-1 |
| Nintedanib Esylate | In domo | DMF/FDA | 656247-18-6 |
| Revefenacin | In domo | DMF | 864750-70-9 |
| Mirabegron | In domo | DMF | 223673-61-8 |
| Escitalopram Oxalate | EP/USP/CP | DMF in processususus | 219861-08-2 |
| Cariprazine hydrochloride | In domo | DMF | 1083076-69-0 |
| Lasmiditan Succinate | In domo | DMF | 439239-92-6 |
| Iuliconazole | In domo | DMF | 187164-19-8 |
| Apalutami | In domo | DMF in processususus | 956104-40-8 |
| Tadalafil | EP/USP/CP | Sub R&D | 171596-29-5 |
| Relugolix | In domo | DMF in processususus | 737789-87-6 |
| Phloroglucinol | CP | DMF | 108-73-6 |
| Acidum Ursodeoxycholic | EP/USP/JP | Sub R&D | 128-13-2 |
| Omega-3-Acid Ethyl Ethers 90 |
EP/USP |
DMF in processusususus |
-- |
| Medium-Chain Triglycerides |
CP/USP/EP |
DMF |
-- |
| Benzalkonium Chloride |
USP/EP/JP |
CEP in processu |
8001-54-5 |
| Oleum olivae (For Iniectio) |
CP/USP/EP/JP |
DMF in processusususus |
8001-25-0 |
| Ovum phospholipids (Nam Iniectio) |
CP/USP/EP |
DMF |
93685-90-6 |
| PORTIO |
In domo |
DMF in processusususus |
203787-91-1 |
- View as
Progesterone
Progesterone EP, USP, CP, JP, IP et KP specificationes habet.CEP in promptu sunt, EU-GMP,FDA approbavit.
CAS:57-83-0
Lege plusMitte Inquisitionem
Finasteride
Finasteride EP, USP, CP, IP, JP in promptu habet, FDA, PMDA et GMP approbavit.
CAS:98319-26-7
Lege plusMitte Inquisitionem
Budesonide
Budesonide habet USP, EP specificationes. CEP, GMP et FDA probatus est.
CAS:51333-22-3
Lege plusMitte Inquisitionem
Dutasteride
Dutasteride EP, USP, CP, IP, JP specificationem habet. CEP et FDA praesto.
CAS:164656-23-9
Lege plusMitte Inquisitionem
Desonide
Desonide USP et EP specificationes habet. DMF praesto.
CAS:638-94-8
Lege plusMitte Inquisitionem
Methylprednisolone
Methylprednisolone specificationes USP, EP, IP, JP, KP habet. DMF and WC available.
CAS: 83-43-2
Lege plusMitte Inquisitionem
Humanwell Pharmaceuticus unus ex maximis API fabricandis in Sinis. Cum plusquam XX annos experientiae, APIs, intermediis et formulis elaboramus, fabricamus et mercaturas steroidales. Forum nostrum toto orbe terrarum operit, praesentias validas habemus in America Septentrionali, Europa, America Meridionali et Africa, cum fructibus plus quam 150 terris venditis.
